Nemora Barcellos
Citado por
Citado por
Raltegravir for the treatment of patients co-infected with HIV and tuberculosis (ANRS 12 180 Reflate TB): a multicentre, phase 2, non-comparative, open-label, randomised trial
B Grinsztejn, N De Castro, V Arnold, VG Veloso, M Morgado, JH Pilotto, ...
The Lancet infectious diseases 14 (6), 459-467, 2014
The HIV-Brazil cohort study: design, methods and participant characteristics
A Grangeiro, MM Escuder, AJF Cassanote, RA Souza, AO Kalichman, ...
Plos one 9 (5), e95673, 2014
Independent predictors of metabolic syndrome in HIV-infected patients
PR Alencastro, SC Fuchs, FH Wolff, ML Ikeda, ABM Brandão, ...
AIDS patient care and STDs 25 (11), 627-634, 2011
Coinfecção HIV/sífilis na gestação e transmissão vertical do HIV: um estudo a partir de dados da vigilância epidemiológica
LMW Acosta, TR Gonçalves, NT Barcellos
Revista Panamericana de Salud Pública 40, 435-442, 2016
Prevalence of and risk factors for HIV infection in individuals testing for HIV at counseling centers in Brazil
NT Barcellos, SC Fuchs, FD Fuchs
Sexually transmitted diseases, 166-173, 2003
Co-infection by hepatitis C virus in HIV-infected patients in southern Brazil: genotype distribution and clinical correlates
FH Wolff, SC Fuchs, NNT Barcellos, PR Alencastro, MLR Ikeda, ...
PloS one 5 (5), e10494, 2010
Estudos de custo-efetividade em saúde no Brasil: uma revisão sistemática
G Moraz, AS Garcez, EM Assis, JP Santos, NT Barcellos, LR Kroeff
Ciência & Saúde Coletiva 20, 3211-3229, 2015
Co‐circulation HIV‐1 subtypes B, C, and CRF31_BC in a drug‐naïve population from Southernmost Brazil: Analysis of primary resistance mutations
RM de Medeiros, DM Junqueira, MCC Matte, NT Barcellos, JAB Chies, ...
Journal of medical virology 83 (10), 1682-1688, 2011
Metabolic syndrome and population attributable risk among HIV/AIDS patients: comparison between NCEP-ATPIII, IDF and AHA/NHLBI definitions
PR Alencastro, FH Wolff, RR Oliveira, MLR Ikeda, NT Barcellos, ...
AIDS research and therapy 9 (1), 1-7, 2012
Alcohol drinking pattern: a comparison between HIV-infected patients and individuals from the general population
MLR Ikeda, NT Barcellos, PR Alencastro, FH Wolff, LB Moreira, M Gus, ...
PLoS One 11 (6), e0158535, 2016
Human T lymphotropic virus type I/II infection: prevalence and risk factors in individuals testing for HIV in counseling centers from Southern Brazil
NT Barcellos, SC Fuchs, LG Mondini, EL Murphy
Sexually transmitted diseases, 302-306, 2006
Risk factors for hepatitis C virus infection in individuals infected with the HIV
FH Wolff, SC Fuchs, NT Barcellos, M Falavigna, M Cohen, ABM Brandão, ...
Digestive and Liver Disease 40 (6), 460-467, 2008
Association of blood pressure and hypertension with alcohol consumption in HIV-infected white and nonwhite patients
MLR Ikeda, NT Barcellos, PR Alencastro, FH Wolff, A Brandão, FD Fuchs, ...
The Scientific World Journal 2013, 2013
Comparison between potential risk factors for cardiovascular disease in people living with HIV/AIDS in areas of Brazil
RAA Ximenes, HR Lacerda, DB Miranda-Filho, PM Maria de Fatima, ...
The Journal of Infection in Developing Countries 9 (09), 988-996, 2015
Strategies to prevent HIV transmission to serodiscordant couples
RC Hallal, JC Raxach, NT Barcellos, I Maksud
Revista Brasileira de Epidemiologia 18, 169-182, 2015
People living with HIV on ART have accurate perception of lipodystrophy signs: a cross-sectional study
PR Alencastro, NT Barcellos, FH Wolff, MLR Ikeda, F Schuelter-Trevisol, ...
BMC Research Notes 10 (1), 1-8, 2017
Gestão e processos de trabalho nos Centros de Testagem e Aconselhamento de Porto Alegre-RS na perspectiva de seus aconselhadores
CB Haag, TR Gonçalves, NT Barcellos
Physis: Revista de Saúde Coletiva 23 (3), 723-739, 2013
Effect of characteristics of pharmacotherapy on non‐adherence in chronic cardiovascular disease: a systematic review and meta‐analysis of observational studies
APH Schneider, MÂ Gaedke, A Garcez, NT Barcellos, VMV Paniz
International Journal of Clinical Practice 72 (1), e13044, 2018
A randomized multicentre open-label trial to estimate the efficacy and safety of two doses of raltegravir (RAL) to efavirenz (EFV) for the treatment of HIV-TB co-infected …
B Grinsztejn, N De Castro, V Arnold, V Veloso, M Morgado, JH Pilotto, ...
First and second COVID-19 waves in Brazil: A cross-sectional study of patients’ characteristics related to hospitalization and in-hospital mortality
FA Zeiser, B Donida, CA da Costa, G de Oliveira Ramos, JN Scherer, ...
The Lancet Regional Health-Americas 6, 100107, 2022
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20